Dendreon Corp (DNDN): Today's Featured Health Care Loser
Dendreon (DNDN) pushed the Health Care sector lower today making it today's featured Health Care loser. The sector as a whole closed the day up 0.8%. By the end of trading, Dendreon fell 32 cents (-4.3%) to $7.20 on average volume. Throughout the day, 6.8 million shares of Dendreon exchanged hands as compared to its average daily volume of 6.7 million shares. The stock ranged in price between $7.15-$7.49 after having opened the day at $7.43 as compared to the previous trading day's close of $7.52. Other company's within the Health Care sector that declined today were: Palatin Technologies (PTN), down 16.5%, Tengion (TNGN), down 15.8%, CEL-SCI Corporation (CVM), down 15%, and Sunshine Heart (SSH), down 9.9%. Dendreon Corporation, a biotechnology company, engages in the discovery, development, and commercialization of novel therapeutics to enhance cancer treatment options for patients. Dendreon has a market cap of $1.19 billion and is part of the drugs industry. Shares are up 2.1% year to date as of the close of trading on Monday. Currently there are four analysts that rate Dendreon a buy, four analysts rate it a sell, and 12 rate it a hold. TheStreet Ratings rates Dendreon as a sell. The company's weaknesses can be seen in multiple areas, such as its disappointing return on equity, generally disappointing historical performance in the stock itself and generally weak debt management.
- You can view the full Dendreon Ratings Report.
- Use our health care section to find sector-relevant news.
- Or find some new ideas from our top rated stocks lists.
- Find other investment ideas from our top rated ETFs lists.
Latest Headlines about DNDN
-
Interesting DNDN Put And Call For June 7th
11:11AM 05/30/13
-
Commit To Buy Dendreon At $2, Earn 26.5%
02:18PM 05/23/13
-
2013 FDA Drug Approval Calendar
07:00AM 05/21/13
-
A Dendreon Shareholder Voices His Frustration at Incompetent Directors
12:14PM 04/22/13
-
Oversold Conditions For Dendreon (DNDN)
04:29PM 04/18/13
-
Most Profitable Second Quarter Biotech Stocks
06:00AM 04/02/13
-
Cramer's 'Mad Money' Recap: It's Time to Pause
08:12PM 03/21/13
Latest from TheStreet Wire
-
Randgold Resources Ltd (GOLD): Today's Featured Basic Materials Laggard
05:01PM 06/18/13
-
Pinnacle West Capital Corporation (PNW): Today's Featured Utilities Laggard
05:01PM 06/18/13
-
Saks Incorporated (SKS): Today's Featured Retail Laggard
05:01PM 06/18/13
-
Catamaran Corp (CTRX): Today's Featured Computer Software & Services Laggard
05:01PM 06/18/13
-
Leucadia National Corporation (LUK): Today's Featured Food & Beverage Laggard
05:01PM 06/18/13
-
Clearwire Corp (CLWR): Today's Featured Telecommunications Laggard
05:01PM 06/18/13
-
Infosys Ltd (INFY): Today's Featured Technology Laggard
05:01PM 06/18/13
Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
TheStreet Quant Ratings
TRY IT FREENew! $49.95/yr
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
Product Features:
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Dividend Stock Advisor
TRY IT FREEJim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
